CGT

868개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved868 programs
CGTLimited DatastalePersonGen BioTherapeutics (Suzh…Preclinical

CD19-CART (CD19-CART)

Autoimmune Disease · CD19

#CD19#CGT#Preclinical#cell-gene-therapy#CAR-T+3
Trials 2Status Recruiting
CGTLimited DatastaleTimmune Biotech Inc.Phase 1

CD19-TriCAR-T/SILK (CD19-TriCAR-T/SILK)

Non-Hodgkin Lymphoma of Intestine; Leukemia · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 2Status Active
CGTLimited DatastaleChina Immunotech Pharmaceutical…Phase 1

CD19/CD20 Dual-CAR-T cells (CD19/CD20 Dual-CAR-T cells)

B-cell Leukemia · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Active
CGTLimited DatastaleUniversity of Colorado, DenverPhase 1

CD19x22 CAR T Cells (CD19x22 CAR T Cells)

Non-Hodgkin Lymphoma; B-cell Non-Hodgkin Lymphoma (B-NHL) · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
CGTLimited DatastaleOneChain ImmunotherapeuticsPhase 1

CD1a-CAR T (CD1a-CAR T)

T-cell Acute Lymphoblastic Leukemia; Lymphoblastic T-Cell Lymphoma · T-cell Acute Lymphoblastic Leukemia

#T-cellAcuteLymphoblasticLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Recruiting
CGTLimited DatastaleGyala TherapeuticsPhase 1

CD84-CART (CD84-CART)

Relapsed/Refractory Acute Myeloid Leukemia(AML) · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
CGTLimited DatastaleBiohaven Pharmaceuticals, Inc.Phase 2

CIML NK Cell Infusion (CIML NK Cell Infusion)

Squamous Cell Carcinoma of the Head and Neck; Recurrent Head and Neck Squamous Cell Carcinoma · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 2Status Active
CGTLimited DatastaleIntima Bioscience, Inc.Phase 2

CISH Inactivated TIL (CISH Inactivated TIL)

Carcinoma, Non-Small-Cell Lung; Metastatic Non Small Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung

#CarcinomaNon-Small-CellLung#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 2Status Discontinued
CGTLimited DatastaleFrontiergate Biopharm（Hainan） C…Phase 1

Claudin18.2-targeted CAR-DCs (Claudin18.2-targeted CAR-DCs)

Colorectal Neoplasia · Colorectal Neoplasia

#ColorectalNeoplasia#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 2Status Recruiting
CGTLimited DatastaleHan weidongPhase 2

Decitabine-primed Tandem CAR19/20 engineered T cells (Decitabine-primed Tandem CAR19/20 engineered T cells)

Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
CGTLimited DatastaleShenzhen Geno-Immune Medical In…Phase 2

GD2, PSMA and CD276 CAR-T cells (GD2, PSMA and CD276 CAR-T cells)

Neuroblastoma · PSMA

#PSMA#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 2Status Recruiting
CGTLimited DatastaleBambino Gesù Hospital and Resea…Phase 2

GD2-CART01 (GD2-CART01)

Neuroblastoma; Neuroblastoma Recurrent · GD2

#GD2#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
CGTLimited DatastaleStanford UniversityPhase 1

GPC2-CAR T cells (GPC2-CAR T cells)

Medulloblastoma; Central Nervous System Embryonal Tumor · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
CGTLimited DatastaleBristol-Myers SquibbPhase 1

IL13Ralpha2-specific Hinge-optimized 4-1BB-co-stimulatory CAR/Truncated CD19-expressing Autologous TN/MEM Cells (IL13Ralpha2-specific Hinge-optimized 4-1BB-co-stimulatory CAR/Truncated CD19-expressing Autologous TN/MEM Cells)

Metastatic Malignant Solid Neoplasm; Metastatic Melanoma · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
CGTLimited DatastaleBeijing Immunochina Medical Sci…Phase 2

IM19 CAR-T cells (IM19 CAR-T cells)

NHL · Leukemia

#Leukemia#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 2Status Active
CGTLimited DatastaleTcelltech Inc.Phase 1

In Vivo CAR-T Therapy (In Vivo CAR-T Therapy)

Graves' Disease · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Recruiting
CGTLimited DatastaleUniversity College, LondonPhase 1

4G7-CARD T-cells (Infusion of modified CAR19 T-cells, Infusion of modified CAR19 T-cells (4G7-CARD T-cells))

CD19+ Malignancies: Relapse Post-allogeneic Transplant · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Active
CGTLimited DatastaleChongqing Precision Biotech Co.…Phase 1

Intraperitoneal infusion of FAST CEA-targeted CAR-T (Intraperitoneal infusion of FAST CEA-targeted CAR-T)

Colorectal Cancer; Stomach Cancer · CEA

#CEA#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 2Status Recruiting
CGTLimited DatastaleJuno Therapeutics, a Subsidiary…Phase 2

JCARH125 (JCARH125)

Non Hodgkin Lymphoma; Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 2Status Active
CGTLimited DatastaleRenJi HospitalPhase 1

JWCAR201 (JWCAR201)

Diffuse Large B Cell Lymphoma · B-cell Tumors

#B-cellTumors#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 2Status Recruiting

12 / 44 pages

← PreviousNext →